OpenAlex
PricingAboutJobs
Log inGet started
Work

Talazoparib: First Global Approval

HTML

Year: 2018
Type: review
Source: Drugs
DOI: 10.1007/s40265-018-1026-z
Author: Sheridan M. Hoy
Institution: Springer Nature (New Zealand)
Language: English

Topic: PARP inhibition in cancer therapy
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: talazoparib, PARP inhibitors, HER2-negative breast cancer, metastatic breast cancer, locally advanced breast cancer, FDA approval, drug development milestones, metastatic castration-resistant prostate cancer, DNA single-strand break repair
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2902946687
FWCI: 1.766
Cites: 26
Cited by: 218
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms